Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
The difficult momentum of Indian pharma sector
GoinPharma
Sun, 03/25/18 - 11:22 am
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Fri, 03/23/18 - 09:52 am
Indivior
patents
Suboxone
Alvogen
generics
Sanofi's for-sale generics unit is too pricey, or so says dropout bidder
Fierce Pharma
Thu, 03/22/18 - 10:43 am
Sanofi
M&A
generics
Nordic Capital
Massachusetts court - Merck can be sued over generic drug injury
Yahoo/Reuters
Sat, 03/17/18 - 10:03 am
Merck
generics
Massachusetts
New FDA Generic Drug Reports Tabulate Approval Times
RAPS.org
Fri, 03/16/18 - 09:25 pm
FDA
generics
drug approvals
Teva takes issue with EC charges of pay-for-delay deal with Cephalon
Seeking Alpha
Wed, 03/14/18 - 09:34 pm
Teva Pharmaceuticals
Europe
pay-for-delay
Cephalon
Provigil
generics
Amgen faces tough one-two blow as competition mounts for Repatha and Sensipar
Fierce Pharma
Tue, 03/13/18 - 09:30 pm
Amgen
Repatha
Sensipar
generics
Sanofi
Regeneron
Praluent
GSK wins new reprieve as Hikma's generic Advair delayed again
Yahoo/Reuters
Tue, 03/13/18 - 11:45 am
GSK
Hikma
generics
Advair
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
FDA
generics
Amgen
Sensipar
Cipla
Aurobindo
Falloff in FDA Generic Drug Approvals Continues Into February
RAPS.org
Wed, 03/7/18 - 06:22 pm
FDA
generics
drug approvals
Healthcare on the Hill - Increasing Competition in Pharmaceuticals Act
CP Wire
Fri, 03/2/18 - 10:12 am
competition
Healthcare on the Hill
FDA
generics
Healthcare on the Hill - Increasing Competition in Pharmaceuticals Act
Sat, 03/3/18 - 02:04 pm
Healthcare on the Hill
FDA
generics
Mylan: Generic competition pushes EpiPen sales down
Drug Delivery Business News
Thu, 03/1/18 - 10:07 am
Mylan Labs
earnings
generics
EpiPens
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fierce Pharma
Tue, 02/27/18 - 11:33 am
Fresenius
Akorn
drug manufacturing
generics
data integrity
FDA
Transitioning Teva revamps branding to emphasize brand-generic unity
Fierce Pharma
Mon, 02/26/18 - 10:50 am
Teva Pharmaceutical
generics
Momenta Pharmaceuticals Wraps Up a Bleak Year
Motley Fool
Fri, 02/23/18 - 07:56 am
Momenta Pharmaceuticals
earnings
biosimilars
generics
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
TheStreet.com
Sat, 02/17/18 - 10:53 am
Novartis
generics
M&A
FDA Form 483 shows Pfizer repeating same mistakes at troubled fill-finish plant
Fierce Pharma
Fri, 02/16/18 - 09:35 pm
FDA
Pfizer
drug manufacturing
Copaxone
generics
Trump pitches changes to 180-day generic exclusivity
Biopharma Dive
Tue, 02/13/18 - 10:45 pm
Donald Trump
generics
exclusivity
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Motley Fool
Fri, 02/9/18 - 09:33 am
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29
…
next ›
last »